S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications
Nitric oxide (NO) is a key signalling molecule released by vascular endothelial cells that is essential for vascular health. Low NO bioactivity is associated with cardiovascular diseases, such as hypertension, atherosclerosis, and heart failure and NO donors are a mainstay of drug treatment. However...
| Principais autores: | , , , , , , , , , , , |
|---|---|
| Formato: | Journal article |
| Idioma: | English |
| Publicado em: |
Elsevier
2024
|
| _version_ | 1826313049155305472 |
|---|---|
| author | Tabish, TA Hussain, MZ Zervou, S Myers, WK Tu, W Xu, J Beer, I Huang, WE Chandrawati, R Crabtree, MJ Winyard, PG Lygate, CA |
| author_facet | Tabish, TA Hussain, MZ Zervou, S Myers, WK Tu, W Xu, J Beer, I Huang, WE Chandrawati, R Crabtree, MJ Winyard, PG Lygate, CA |
| author_sort | Tabish, TA |
| collection | OXFORD |
| description | Nitric oxide (NO) is a key signalling molecule released by vascular endothelial cells that is essential for vascular health. Low NO bioactivity is associated with cardiovascular diseases, such as hypertension, atherosclerosis, and heart failure and NO donors are a mainstay of drug treatment. However, many NO donors are associated with the development of tolerance and adverse effects, so new formulations for controlled and targeted release of NO would be advantageous. Herein, we describe the design and characterisation of a novel NO delivery system via the reaction of acidified sodium nitrite with thiol groups that had been introduced by cysteamine conjugation to porous graphene oxide nanosheets, thereby generating S-nitrosated nanosheets. An NO electrode, ozone-based chemiluminescence and electron paramagnetic resonance spectroscopy were used to measure NO released from various graphene formulations, which was sustained at >5 × 10<sup>−10</sup> mol cm<sup>−2</sup> min<sup>−1</sup> for at least 3 h, compared with healthy endothelium (cf. 0.5–4 × 10<sup>−10</sup> mol cm<sup>−2</sup> min<sup>−1</sup>). Single cell Raman micro-spectroscopy showed that vascular endothelial and smooth muscle cells (SMCs) took up graphene nanostructures, with intracellular NO release detected via a fluorescent NO-specific probe. Functionalised graphene had a dose-dependent effect to promote proliferation in endothelial cells and to inhibit growth in SMCs, which was associated with cGMP release indicating intracellular activation of canonical NO signalling. Chemiluminescence detected negligible production of toxic N-nitrosamines. Our findings demonstrate the utility of porous graphene oxide as a NO delivery vehicle to release physiologically relevant amounts of NO in vitro, thereby highlighting the potential of these formulations as a strategy for the treatment of cardiovascular diseases. |
| first_indexed | 2024-09-25T04:04:53Z |
| format | Journal article |
| id | oxford-uuid:3a1f3794-2e03-47bd-b398-4f308ee1424c |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-09-25T04:04:53Z |
| publishDate | 2024 |
| publisher | Elsevier |
| record_format | dspace |
| spelling | oxford-uuid:3a1f3794-2e03-47bd-b398-4f308ee1424c2024-05-22T15:42:28ZS-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applicationsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:3a1f3794-2e03-47bd-b398-4f308ee1424cEnglishSymplectic ElementsElsevier2024Tabish, TAHussain, MZZervou, SMyers, WKTu, WXu, JBeer, IHuang, WEChandrawati, RCrabtree, MJWinyard, PGLygate, CANitric oxide (NO) is a key signalling molecule released by vascular endothelial cells that is essential for vascular health. Low NO bioactivity is associated with cardiovascular diseases, such as hypertension, atherosclerosis, and heart failure and NO donors are a mainstay of drug treatment. However, many NO donors are associated with the development of tolerance and adverse effects, so new formulations for controlled and targeted release of NO would be advantageous. Herein, we describe the design and characterisation of a novel NO delivery system via the reaction of acidified sodium nitrite with thiol groups that had been introduced by cysteamine conjugation to porous graphene oxide nanosheets, thereby generating S-nitrosated nanosheets. An NO electrode, ozone-based chemiluminescence and electron paramagnetic resonance spectroscopy were used to measure NO released from various graphene formulations, which was sustained at >5 × 10<sup>−10</sup> mol cm<sup>−2</sup> min<sup>−1</sup> for at least 3 h, compared with healthy endothelium (cf. 0.5–4 × 10<sup>−10</sup> mol cm<sup>−2</sup> min<sup>−1</sup>). Single cell Raman micro-spectroscopy showed that vascular endothelial and smooth muscle cells (SMCs) took up graphene nanostructures, with intracellular NO release detected via a fluorescent NO-specific probe. Functionalised graphene had a dose-dependent effect to promote proliferation in endothelial cells and to inhibit growth in SMCs, which was associated with cGMP release indicating intracellular activation of canonical NO signalling. Chemiluminescence detected negligible production of toxic N-nitrosamines. Our findings demonstrate the utility of porous graphene oxide as a NO delivery vehicle to release physiologically relevant amounts of NO in vitro, thereby highlighting the potential of these formulations as a strategy for the treatment of cardiovascular diseases. |
| spellingShingle | Tabish, TA Hussain, MZ Zervou, S Myers, WK Tu, W Xu, J Beer, I Huang, WE Chandrawati, R Crabtree, MJ Winyard, PG Lygate, CA S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications |
| title | S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications |
| title_full | S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications |
| title_fullStr | S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications |
| title_full_unstemmed | S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications |
| title_short | S-nitrosocysteamine-functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications |
| title_sort | s nitrosocysteamine functionalised porous graphene oxide nanosheets as nitric oxide delivery vehicles for cardiovascular applications |
| work_keys_str_mv | AT tabishta snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT hussainmz snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT zervous snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT myerswk snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT tuw snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT xuj snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT beeri snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT huangwe snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT chandrawatir snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT crabtreemj snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT winyardpg snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications AT lygateca snitrosocysteaminefunctionalisedporousgrapheneoxidenanosheetsasnitricoxidedeliveryvehiclesforcardiovascularapplications |